N@N

MRK, CMN, SYNO, SUI, COMS. Top Losing Stocks With Negative Price Friction In Morning Trade Today

^{Published on 2009-07-09 09:48:20, Last Modified on 2010-12-22 14:27:48 - WOPRAI}
 

July 9, 2009 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for July 9, 2009. Since late October market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This afair market makinga requirement is designed to prevent market makers from manipulating stock prices. Here is a list of the top companies with the largest losses this morning and negative price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Merck and Co. (NYSE: MRK), Cantel Medical Group (NYSE: CMN), Synovis Life Technologies (NASDAQ: SYNO), Sun Communities (NYSE: SUI) and 3COM Corp (NASDAQ: COMS). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

Symbol Change % BuyVol Buy% SellVol Sell% NetVol Friction

MRK -$1.04 -3.71% 2,680,983 35.00% 3,324,137 43.39% -643,154 -6,184

AVF -$0.98 -11.81% 59,505 20.28% 169,480 57.75% -109,975 -1,122

CMN -$0.74 -5.06% 12,376 34.59% 18,305 51.16% -5,929 -80

SYNO -$0.70 -3.99% 12,746 34.64% 23,528 63.95% -10,782 -154

SUI -$0.70 -4.92% 27,720 38.43% 43,903 60.87% -16,183 -231

COMS -$0.53 -11.28% 2,041,618 38.45% 3,194,025 60.15% -1,152,407 -21,744

Click here to view chart:

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net dollar losses (Change) and extremely low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows MRK with a dollar loss this morning of -$1.04 and a Friction Factor of -6,184 shares. That means that it only takes 6,184 more shares of selling than buying to move MRK lower by one penny. This means the Market Makers are allowing the stock to drop quickly (low friction). The combination of low friction and negative market direction can drive prices lower faster than normal.

Merck & Co., Inc. (NYSE: MRK) provides products for human and animal health in the United States and internationally. The companya�s Pharmaceutical segment offers human health pharmaceutical products, such as therapeutic and preventive agents. Its products comprise Singulair, a leukotriene receptor antagonist for the treatment of asthma and allergic rhinitis; Cozaar, Hyzaar, Vasotec, and Vaseretic, the hypertension and/or heart failure products; Fosamax and Fosamax Plus D for treating osteoporosis; Januvia and Janumet for type 2 diabetes; Cosopt and Trusopt, the ophthalmological products; Zocor, an atherosclerosis product; Maxalt for acute migraine; Propecia to treat male pattern hair loss; Arcoxia to treat arthritis and pain; Proscar to treat symptomatic benign prostate enlargement; and Emend for the prevention of chemotherapy-induced and post-operative nausea and vomiting. Merck & Co.a�s Vaccines segment comprises human health vaccines, such as preventative pediatric, adolescent, and adult vaccines administered at physician offices. Its products include Gardasil to prevent cervical cancer, pre-cancerous and low-grade lesions, vulvar and vaginal pre-cancers, and genital warts; Varivax to prevent chickenpox; ProQuad, a pediatric combination vaccine against measles, mumps, rubella, and varicella; M-M-R II, a vaccine against measles, mumps, and rubella; RotaTeq to protect against rotavirus gastroenteritis in children; Zostavax for preventing shingles; Primaxin and Cancidas, anti-bacterial/anti-fungal products; Isentress, Crixivan, and Stocrin, antiretroviral therapies for the treatment of HIV infection; and Invanz for the treatment of infection. Merck & Co. has research, collaboration, or licensing agreements with Neuromed Pharmaceuticals, Ltd.; ARIAD Pharmaceuticals, Inc.; GTX, Inc.; Idera Pharmaceuticals; Japan Tobacco Inc.; Galapagos NV; AstraZeneca plc; and Metabasis Therapeutics Inc. The company was founded in 1891 and is headquartered in Whitehouse Station, New Jersey.

Cantel Medical Corp. (NYSE: CMN) provides infection prevention and control products for the healthcare market primarily in the United States. It operates in six segments: Water Purification and Filtration, Dialysis, Healthcare Disposables, Endoscope Reprocessing, Therapeutic Filtration, and Specialty Packaging. The Water Purification and Filtration segment provides water purification equipment and services, filtration and separation products, and disinfectants for the medical, pharmaceutical, biotech, beverage, and commercial industrial markets. The Dialysis segment offers medical device reprocessing systems, sterilants/disinfectants, dialysate concentrates, and other supplies for renal dialysis. The Healthcare Disposables segment provides single-use, infection control products, including face masks, towels and bibs, tray covers, saliva ejectors, germicidal wipes, plastic cups, sterilization pouches, and disinfectants used principally in the dental market. The Endoscope Reprocessing segment offers medical device reprocessing systems and sterilants/disinfectants for endoscopy. The Therapeutic Filtration segment provides hollow fiber membrane filtration and separation technologies for medical applications. The Specialty Packaging segment offers specialty packaging and thermal control products, as well as related compliance training, for the transport of infectious and biological specimens and thermally sensitive pharmaceutical, and other medical products. The company sells its products through its own direct distribution network, as well as through third-party distributors. Cantel also operates in Canada, the Asia Pacific, Europe, Africa, the Middle East, and Latin America/South America. The company was founded in 1963 and is based in Little Falls, New Jersey.

Synovis Life Technologies, Inc. (NASDAQ: SYNO), a medical device company, engages in the development, manufacture, marketing, and sale of products for the surgical treatment of diseases. Its products include implantable biomaterial products and devices for microsurgery and surgical tools, which are used to reduce risk and/or facilitate critical surgeries. The companya�s biomaterial products include Peri-Strips that are biomaterial stapling buttress used as reinforcement at the surgical staple line; Tissue-Guard, which is used to repair and replace damaged tissue in cardiac, vascular, thoracic, and neurologic procedures; and Veritas Collagen Matrix for use in surgery to repair and replace soft tissue. Its devices for microsurgery comprise Microvascular Anastomotic Coupler, which enables microsurgeons in various surgical specialties to perform anastomotic microsurgical procedures; and Neurotube, a device designed to assist in the reconnection of severed nerves. Synovis Life Technologies sells its products through direct sales force and independent distributors primarily in the United States, Europe, Canada, and the Asia Pacific region. The company, formerly known as Bio-Vascular, Inc., was founded in 1985 and is headquartered in St. Paul, Minnesota.

Sun Communities, Inc. (NYSE: SUI) operates as a real estate investment trust (REIT). The company owns, operates, and develops manufactured housing communities concentrated in the midwestern, southern, and southeastern United States. As of December 31, 2008, it owned and operated a portfolio of 136 properties located in 18 states, including 124 manufactured housing communities, 4 recreational vehicle communities, and 8 properties containing manufactured housing and recreational vehicle sites. The companya�s properties contained approximately 47613 developed sites, which comprised of 42299 developed manufactured home sites, 3107 permanent recreational vehicle sites, and 2207 seasonal recreational vehicle sites; and 6081 manufactured home sites for development. As a REIT, Sun Communities would not be subject to federal tax to the extent that it distributes at least 90% of its taxable income to its shareholders. The company was founded in 1975 and is based in Southfield, Michigan.

3Com Corporation (NASDAQ: COMS) provides secure and converged networking solutions that enable customers to manage voice, video, and data in a secure network environment. The companya�s products and services include networking solutions, including Ethernet switching, local area network (LAN) switches, routers, unified switching solutions, and network management software; Internet protocol (IP) telephony solutions comprising IP telephony platforms, convergence application suite, and IP phones; and security solutions, such as intrusion prevention systems, network access control systems, and firewalls. The company also offers a range of professional services, such as assessment and design, project management, training and certifications, installation, and integration services, as well as open services networking services. 3Com markets and sells its products primarily through value-added partners, direct sales representatives, distributors, and resellers, as well as through systems integrators, service providers, and direct marketers. The company primarily serves enterprise and small and medium-sized business customers in various industries, including education, finance, government, healthcare, insurance, manufacturing, and real estate. It has operations in the Americas, Europe, Africa, and China, as well as in the Middle East and the Asia Pacific regions. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.

About BUYINS.NET

WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.

BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2,550,000,000 short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha�s short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. None of the companies in this report have paid to be included in this report. From time to time we will mention a company that may have previously paid $995 per month for market data purchased from BUYINS.NET. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

BUYINS.NET, FRICTION FACTOR and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of BUYINS.NET, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting BUYINS.NET or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. BUYINS.NET, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to BUYINS.NET and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State. Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. BUYINS.NET does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. BUYINS.NET places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.BUYINS.net +1-800-715-9999 Tom@buyins.net